[Answered] Louis XIV's economic policy was called A. laissez-faire. B. mercantilism. C. the guild system. ...

This topic contains a solution. Click here to go to the answer

Author Question: Louis XIV's economic policy was called A. laissez-faire. B. mercantilism. C. the guild system. ... (Read 89 times)

Jkov05

Hero Member
Posts: 556

on: Sep 28, 2018

Louis XIV's economic policy was called

A. laissez-faire.
B. mercantilism.
C. the guild system.
D. capitalism.

Question 2

Which state briefly became a republic (called the Commonwealth) in the mid-seventeenth century?

A. England
B. France
C. Spain
D. Austria

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

sultansheikh

Sr. Member
Posts: 335

Reply #1 on: Sep 28, 2018

Answer to Question 1

B

Answer to Question 2

A

Jkov05

Member
Posts: 556

Reply 2 on: Sep 28, 2018

Great answer, keep it coming

alexanderhamilton

Member
Posts: 334

Reply 3 on: Yesterday

Thanks for the timely response, appreciate it

« previous next »

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.